CLINICAL_TRIALS
other
· 2026-03-06
Clinical Trial Update: TOP 2301: Neoadjuvant Chemo for NSCLC [Phase 2]
Summary
A Phase 2 trial TOP 2301 evaluating neoadjuvant chemotherapy for non-small cell lung cancer has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: SUSPENDED